{"SPADE_N_06774": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06774", "Peptide Name": "Tritrp DiSu", "Source": "porcine cathelicidin peptide", "Family": "", "Gene": "Not found", "Sequence": "CVRRFPWWYPFLRRC", "Sequence Length": 15, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:Jurkat (IC50=12.3 µM)", "Hemolytic Activity": "RBC:IC50=20.9 µM", "Cytotoxicity": "PBMC:IC50=26.2 µM", "Binding Target": "Not available", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C100H141N29O17S2", "Mass": 2085.5, "PI": 10.72, "Net Charge": 4, "Hydrophobicity": -0.38, "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Selective anticancer activity of synthetic peptides derived from the host defence peptide tritrpticin", "Pubmed ID": "32126228", "Reference": "Biochim Biophys Acta Biomembr. 2020 Aug 1;1862(8)183228.", "Author": "Arias M, Haney EF, Hilchie AL, Corcoran JA, Hyndman ME, Hancock REW, Vogel HJ.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32126228"}], "Frequent Amino Acids": "RCF", "Absent Amino Acids": "ADEGHIKMNOQSTU", "Basic Residues": 4, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 8, "Positive Residues": 4, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_09255", "Similarity": 1.0, "Sequence": "GVRCVCRRGVCRCVRR"}, {"SPADE_ID": "SPADE_N_09256", "Similarity": 1.0, "Sequence": "GVRCVRRGVRCVRR"}, {"SPADE_ID": "SPADE_UN_03216", "Similarity": 1.0, "Sequence": "RRWRIVVICVRR"}]}}}